CROI 2019 Program and Conference Information

Poster Sessions

468 THE ROLE OF OATP1B1 IN GRAZOPREVIR DRUG-DRUG INTERACTIONS AND THE ELDERLY Hannah Kinvig, Felix Stader, Owain Roberts, Andrew Owen, Catia Marzolini, Marco Siccardi INTRACELLULAR SOFOSBUVIR (SOF) CONCENTRATIONS IN PERSONSWITHHCV AND COCAINE USE Kristina M. Brooks, Jose R. Castillo-Mancilla, Mary Morrow, Samantha MaWhinney, Ryan T. Huntley, Joshua Blum, David L. Wyles, Lane R. Bushman, Peter L. Anderson, Jennifer J. Kiser PREDICTION OF RENAL OAT1 AND OAT3 INHIBITION BY CABOTEGRAVIR USING PBPKMODELLING Kunal S. Taskar, Aarti Patel, Simon J. Cozens, Susan Ford, William Spreen, MArk Baker, Parul Patel INFLUENCE OF UGT1A1*28 ON RALTEGRAVIR PK/PD IN THE NEAT001/ANRS143 STUDY Rohan M. Gurjar, Laura Dickinson, Daniel F. Carr, Wolfgang Stohr, Stefano Bonora, Andrew Owen, Antonio D'Avolio, Adam Cursley, Jean-Michel Molina, Gerd Fätkenheuer, Giovanni Di Perri, Anton Pozniak, Laura Richert, François Raffi, Marta Boffito PHARMACOGENETICS OFWEIGHT GAIN AFTER SWITCH FROM EFAVIRENZ TO INTEGRASE INHIBITORS Michael Leonard, Kassem Bourgi, John R. Koethe, Megan M. Turner, Jamison Norwood, Beverly O. Woodward, Husamettin Erdem, Rebecca Basham, Paxton Baker, Peter F. Rebeiro, Timothy R. Sterling, Todd Hulgan, David Haas HORMONAL CONTRACEPTIVES DO NOT ALTER CABOTEGRAVIR PK INHIV-UNINFECTEDWOMENHPTN 077 Cherie Blair, Sue Li, Gordon Chau, Leslie Cottle, Paul Richardson, Mark A. Marzinke, Susan H. Eshleman, Adeola Adeyeye, David Burns, Alex Rinehart, David A. Margolis, Marybeth McCauley, Craig W. Hendrix, Raphael J. Landovitz, for the HPTN 077 Study Team Poster P-H3 VIROLOGIC FAILURES: TO SECOND LINE AND BEYOND Poster Hall - 4EF 2:30 PM - 4:00 PM 495 DISCONTINUATIONS &VIROLOGIC RESPONSE IN LATE PRESENTERSWITH InSTI- OR PI-BASED ART Gundolf Schuettfort, Lena Boekenkamp, Alfonso Cabello, Aoife G. Cotter, Marta Del Palacio Tamarit, Miguel Górgolas, Lisa Hamzah, Eva Herrmann, Pavel Khaykin, Patrick W. Mallon, Alvaro Mena, Caroline Sabin, Timo Wolf, Christoph Stephan, Annette E. Haberl QUALITY OF LIFE AND ADHERENCE AS PREDICTORS OF SECOND- LINE ART VIROLOGICAL FAILURE Thiago S. Torres, Linda J. Harrison, Alberto M. La Rosa, Lu Zheng, Ann Collier, Michael D. Hughes, for the AIDS Clinical Trials Group (ACTG) A5273 Study Group 469 470 471 472 473 496 LOWLEVEL VIREMIA ANDVIROLOGIC FAILURE IN PERSONSWITH HIV TREATEDWITH ART Julia Fleming, Kelly Gebo, Richard Rutstein, W. C. Mathews, Judith Aberg, Charurut Somboonwit, Laura W. Cheever, Richard D. Moore, for the HIV Research Network SECOND-LINE ANTIRETROVIRAL THERAPY (ART) AFTER FIRST VIRAL FAILURE ON ART, 2008-2016 Thibaut Davy-Mendez, Sonia Napravnik, Oksana Zakharova, Joseph J. Eron 498 497

Poster Sessions • Wednesday

CROI 2019 103